摘要
目的探讨调强放疗在甲状腺癌术后残留和复发治疗中的临床效果。方法选择行甲状腺癌手术治疗的患者78例,采用随机数字表法分为两组,各39例。研究组采用调强放疗,对照组行常规放疗治疗,共治疗4周。对比两组临床疗效、术后生存率及不良反应。结果研究组治疗率为84.62%,高于对照组的58.97%,差异有统计学意义(P<0.05);研究组术后1年生存率为100.00%,术后3年生存率为76.92%,均高于对照组的76.92%、61.54%,差异有统计学意义(P<0.05);研究组不良反应发生率为33.33%,低于对照组的56.61%,差异有统计学意义(P<0.05)。结论采用调强放疗治疗甲状腺癌术后残留及复发中能够有效改善患者病情,延长患者生存时间,降低并发症发生率,疗效确切。
Objective To investigate the clinical effect of intensive radiotherapy in residue and recurrence after thyroid cancer.Methods 78 patients treated with thyroid cancer from October 2016 to December 2018 were divided into two groups and 39 cases each.The study group used intensive modulation radiotherapy,and the control group underwent routine radiotherapy for a total of 4 weeks.Comparing the clinical efficacy,postoperative survival rate,and adverse reactions between the 2 groups.Results The treatment rate was 84.62%,higher than 58.97%,statistically significant(P<0.05),100.00%,76.92%,all above 76.92%,76.92%,61.54%(P<0.05);adverse reactions were 33.33%,below 56.61%and significant(P<0.05).Conclusion The treatment of intensive radiotherapy for thyroid cancer can effectively improve the condition,prolong the survival time and reduce the incidence of complications.
作者
纪玲霞
周爱琴
周雪梅
JI Lingxia;ZHOU Aiqin;ZHOU Xuemei(The Second Affiliated Hospital of Zhengzhou University,Zhengzhou,450003)
出处
《实用癌症杂志》
2022年第5期858-860,共3页
The Practical Journal of Cancer
基金
河南省医学科技攻关计划(编号:20180212690)。
关键词
甲状腺癌
残留
复发
调强放疗
治疗效果
Thyroid cancer
Residue
Recurrence
Intensive radiotherapy
Treatment effect
